EF-36/Keynote B36: A pilot, single arm, open-label study of Tumor Treating Fields (TTFields, 150 kHz) concomitant with pembrolizumab for first line treatment of advanced or metastatic intrathoracic non-small cell lung cancer

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Device Feasibility

Locations

Memorial Hospital Central
Memorial Hospital North

Study ID

Protocol Number: 21-3694

More information available at ClinicalTrials.gov: NCT04892472

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers